Tocilizumab in Refractory ASS-ILD
NCT07662265
·
clinicaltrials.gov ↗
COMPLETED
Status
111
Enrollment
OTHER
Sponsor class
Conditions
Antisynthetase Syndrome
Tocilizumab
Interventions
DRUG:
Tociliuzumab
Sponsor
Hu Yinan